RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 136 filers reported holding RELAY THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $425,210 | -30.3% | 50,560 | +4.1% | 0.14% | -26.2% |
| Q2 2023 | $609,914 | +37.7% | 48,560 | +80.6% | 0.18% | +30.7% |
| Q1 2023 | $442,796 | +3.0% | 26,885 | -6.6% | 0.14% | -6.7% |
| Q4 2022 | $430,048 | -26.0% | 28,785 | +10.8% | 0.15% | -27.5% |
| Q3 2022 | $581,000 | +43.1% | 25,985 | +7.1% | 0.21% | +48.9% |
| Q2 2022 | $406,000 | -39.7% | 24,260 | +8.0% | 0.14% | -30.8% |
| Q1 2022 | $673,000 | -16.3% | 22,470 | -14.1% | 0.20% | -2.0% |
| Q4 2021 | $804,000 | -25.4% | 26,170 | -23.5% | 0.20% | -21.5% |
| Q3 2021 | $1,078,000 | -13.5% | 34,194 | +0.4% | 0.26% | -7.1% |
| Q2 2021 | $1,246,000 | +45.1% | 34,044 | +37.0% | 0.28% | +19.1% |
| Q1 2021 | $859,000 | +112.1% | 24,855 | +154.9% | 0.24% | +95.0% |
| Q4 2020 | $405,000 | – | 9,750 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |